Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where F.P. Antonucci is active.

Publication


Featured researches published by F.P. Antonucci.


Liver International | 2017

Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies

Velia Chiara Di Maio; V. Cento; I. Lenci; M. Aragri; Piera Rossi; S. Barbaliscia; M. Melis; Gabriella Verucchi; Carlo Magni; Elisabetta Teti; A. Bertoli; F.P. Antonucci; Maria Concetta Bellocchi; Valeria Micheli; C. Masetti; Simona Landonio; S. Francioso; F. Santopaolo; A. Pellicelli; V. Calvaruso; Laura Gianserra; M. Siciliano; Dante Romagnoli; R. Cozzolongo; Antonio Grieco; Jacopo Vecchiet; F. Morisco; M. Merli; Giuseppina Brancaccio; Antonio Di Biagio

Despite the excellent efficacy of direct‐acting antivirals (DAA) reported in clinical trials, virological failures can occur, often associated with the development of resistance‐associated substitutions (RASs). This study aimed to characterize the presence of clinically relevant RASs to all classes in real‐life DAA failures.


Journal of Hepatology | 2013

166 HCV DIVERSITY AND FIBROSIS PROGRESSION: NS5A AND CORE VARIANTS CORRELATE WITH SEVERITY OF HCV RECURRENCE AFTER LIVER TRANSPLANTATION

I. Lenci; S. Cucchiarelli; V.C. Di Maio; V. Cento; F. De Luca; M. Milana; F.P. Antonucci; D. Di Paolo; E. Giardina; G. Tisone; M. Angelico; C.F. Perno; Francesca Ceccherini-Silberstein

Results: The overall 1-, 5and 10-year posttransplant survival rates, stratified by the composite risk score are presented in table 1. More than half (53.6%) of patients had at least one of the risk factors (obesity, renal dysfunction or advanced age). Patients with two or more risk factors (score ≥2) experienced a significantly higher covariate-adjusted risk of death compared to patients with zero (HR: 5.9, 95%CI: 2.3–14.3; p < 0.001) or one (HR: 2.6, 95%CI: 1.3–5.6; p = 0.009) risk factor.


Journal of Hepatology | 2013

63 CORRELATION OF EARLY DETECTION OF HCV NS3-RESISTANCE AND VIROLOGICAL FAILURE IN PATIENTS TREATED WITH TRIPLE THERAPY INCLUDING TELAPREVIR OR BOCEPREVIR

V. Cento; V.C. Di Maio; D. Di Paolo; F. De Luca; Valeria Micheli; Monica Tontodonati; Maria Concetta Bellocchi; L. Carioti; Daniele Armenia; F. De Leonardis; F.P. Antonucci; G. Madeddu; Carlo Magni; C. Sarrecchia; Sergio Babudieri; Giustino Parruti; M. Angelico; Giuliano Rizzardini; C.F. Perno; Francesca Ceccherini-Silberstein

63 CORRELATION OF EARLY DETECTION OF HCV NS3-RESISTANCE AND VIROLOGICAL FAILURE IN PATIENTS TREATED WITH TRIPLE THERAPY INCLUDING TELAPREVIR OR BOCEPREVIR V. Cento, V.C. Di Maio, D. Di Paolo, F. De Luca, V. Micheli, M. Tontodonati, M.C. Bellocchi, L. Carioti, D. Armenia, F. De Leonardis, F.P. Antonucci, G. Madeddu, C. Magni, C. Sarrecchia, S. Babudieri, G. Parruti, M. Angelico, G. Rizzardini, C.F. Perno, F. Ceccherini-Silberstein. University of Rome Tor Vergata, University Hospital of Rome Tor Vergata, Roma, Hospital Sacco of Milan, Milan, Infectious Disease Clinic of Chieti, Chieti, University of Sassari, Sassari, Pescara General Hospital, Pescara, Italy E-mail: [email protected]


Journal of Hepatology | 2017

Multiclass hepatitis C virus resistance to direct acting antivirals in real life interferon-free regimens failures advocates for tailored second-line therapies

V.C. Di Maio; V. Cento; I. Lenci; M. Aragri; S. Barbaliscia; S. Francioso; Stefania Paolucci; M. Melis; G. Verucchi; Nicola Coppola; Carlo Magni; Valeria Micheli; Teresa Pollicino; T. Ruggiero; F. Santopaolo; Simona Landonio; A. Mancon; Mario Starace; A. Bertoli; F.P. Antonucci; C. D’Ambrosio; V. Calvaruso; F. Morisco; C. Pasquazzi; I. Maida; A. Picciotto; Antonio Di Biagio; Bianca Bruzzone; L. Sticchi; Valeria Ghisetti


Journal of Virological Methods | 2017

HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay

F.P. Antonucci; V. Cento; M.C. Sorbo; Matteo Ciancio Manuelli; I. Lenci; D. Sforza; Domenico Di Carlo; M. Milana; Tommaso Maria Manzia; Mario Angelico; G. Tisone; Carlo Federico Perno; Francesca Ceccherini-Silberstein


Digestive and Liver Disease | 2017

Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapies

V.C. Di Maio; V. Cento; I. Lenci; M. Aragri; S. Barbaliscia; S. Francioso; Stefania Paolucci; M. Melis; G. Verucchi; C. Masetti; Nicola Coppola; Carlo Magni; Valeria Micheli; Teresa Pollicino; T. Ruggiero; Simona Landonio; A. Mancon; Mario Starace; F. De Leonardis; F. Santopaolo; A. Bertoli; F.P. Antonucci; C. D’Ambrosio; V. Calvaruso; M.C. Sorbo; F. Morisco; C. Pasquazzi; Ivana Maida; A. Picciotto; A. Di Biagio


Journal of Hepatology | 2016

Different Prevalence of HCV Resistance and HCV RNA Quantification Within Tumoral and Non Tumoral Liver Tissues in HCC/Transplanted Patients

M.C. Sorbo; F.P. Antonucci; M. Manuelli; I. Lenci; D. Sforza; L. Carioti; Maria Concetta Bellocchi; V. Cento; D. Di Paolo; F. De Leonardis; M. Milana; T.M. Manzia; G. Tisone; M. Angelico; C.F. Perno; Francesca Ceccherini-Silberstein


Journal of Hepatology | 2016

In the ERA of New Direct Acting Antiviral Agents HCV Sequencing Allows the Most Accurate Subtype and Genotype Assignment

M. Aragri; V.C. Di Maio; D. Di Paolo; V. Cento; F. De Leonardis; Laura Gianserra; Monica Tontodonati; Valeria Micheli; Simona Landonio; A. Manunta; A. Bertoli; Massimo Ciotti; F.P. Antonucci; I. Lenci; S. Francioso; L.A. Nicolini; S. Marenco; Elisabetta Teti; L. Lambiase; M. Milana; I. Maida; A. Di Biagio; A. Pellicelli; L. Nosotti; Stefania Grieco; P. Cacciatore; Dante Romagnoli; M. Siciliano; G. D’Ettorre; Sergio Babudieri


Journal of Hepatology | 2015

P0915 : Clinical relevance of baseline/early detection and persistence of resistant associated variants in HCV-1 patients treated with protease-inhibitors assessed by ultra-deep sequencing

V.C. Di Maio; Daniele Armenia; Maria Concetta Bellocchi; D. Di Paolo; V. Cento; Monica Tontodonati; Valeria Micheli; L. Carioti; F. De Leonardis; M. Aragri; Ennio Polilli; A. Manunta; Carlo Magni; F.P. Antonucci; F. De Luca; C. Sarrecchia; A. Bertoli; I. Lenci; S. Francioso; Maria Mercedes Santoro; Jacopo Vecchiet; A. De Maria; A. Picciotto; L. Nosotti; F. Morisco; Sessa Bruno; Massimo Puoti; Sergio Babudieri; Maria Stella Mura; Gloria Taliani


Digestive and Liver Disease | 2017

Prevalence and characteristics of resistance associated substitutions in DAA-naive and DAA-failed HCV-3 patients in Italy

V.C. Di Maio; S. Barbaliscia; I. Lenci; Elisabetta Teti; F.P. Antonucci; V. Cento; M. Aragri; Stefania Paolucci; Bianca Bruzzone; Nicola Coppola; T. Ruggiero; Teresa Pollicino; Ennio Polilli; C. Pasquazzi; V. Pace Palitti; Carlo Magni; Valeria Micheli; A. Di Biagio; L. Sticchi; M. Melis; S. Francioso; C. Masetti; L. Foroghi; C. Sarrecchia; Leonardo Baiocchi; Simona Landonio; A. Bertoli; V. Calvaruso; F. Morisco; Ivana Maida

Collaboration


Dive into the F.P. Antonucci's collaboration.

Top Co-Authors

Avatar

V. Cento

University of Rome Tor Vergata

View shared research outputs
Top Co-Authors

Avatar

V.C. Di Maio

University of Rome Tor Vergata

View shared research outputs
Top Co-Authors

Avatar

I. Lenci

University of Rome Tor Vergata

View shared research outputs
Top Co-Authors

Avatar

D. Di Paolo

University of Rome Tor Vergata

View shared research outputs
Top Co-Authors

Avatar

A. Bertoli

University of Rome Tor Vergata

View shared research outputs
Top Co-Authors

Avatar

M. Aragri

University of Rome Tor Vergata

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

F. De Leonardis

University of Rome Tor Vergata

View shared research outputs
Top Co-Authors

Avatar

S. Francioso

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge